This federal contract award, valued at $7,518.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream in 60-gram quantities, with a completion date of December 27, 2024.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as a primary vehicle for efficiently procuring essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any major subcontractors. The DLA, as a defense agency, plays a critical role in supplying medical products to federal government agencies, particularly military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/27/25, 9:47 AM